Overview

Study of PAH Subjects With LTOT Use That Have Demonstrated Improved Exercise Tolerance With the Use of Inhaled Nitric

Status:
Withdrawn
Trial end date:
2020-06-01
Target enrollment:
Participant gender:
Summary
Study of PAH Subjects with LTOT Use that have Demonstrated Improved Exercise Tolerance with the use of Inhaled Nitric Oxide
Phase:
Phase 3
Details
Lead Sponsor:
Bellerophon Pulse Technologies
Collaborator:
Worldwide Clinical Trials
Treatments:
Nitric Oxide